How do you approach the risk/benefit discussion with patients when you are considering starting menopausal HRT?

Particularly in low risk patient in regards to typical ASE of HRT.

Ask a clinical question

Answers grounded in the literature and physician expertise.

Related Questions

How would you approach hormone replacement therapy for perimenopause in a patient with increased risk factors for VTE?

What strategies do you recommend for discussing the use of OCP in women with a history of migraines with or without aura?

Do you start bisphosphonates after tapering off menopausal hormone therapy to prevent the rapid decline of bone mineral density?

About Mednet

A community where doctors find answers to medicine's toughest questions.

Verified, credentialed physicians
45,000+ members across 23 specialties
Free CME and MOC credit

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
Mobile App

Company

About
Careers
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.